Research Report on China's Anlotinib Hydrochloride Market, 2021-2025

Publisher Name :
Date: 26-Nov-2021
No. of pages: 40

Anlotinib hydrochloride is a novel small molecule multi-target tyrosine kinase inhibitor that effectively inhibits kinases like VEGFR, PDGFR, FGFR, and c-Kit with anti-tumor angiogenesis and tumor growth inhibition effects. The drug is a new Category 1.1 antitumor drug developed by the Chinese pharmaceutical company Nanjing Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Its clinical trials are already underway for a variety of cancers, including non-small cell lung cancer, soft tissue sarcoma, gastric cancer, colorectal cancer, medullary thyroid cancer, differentiated thyroid cancer, and esophageal squamous cancer.

Anlotinib hydrochloride was approved for marketing under the trade name FuKeWei® by the NMPA on May 9, 2018 for the third-line treatment of patients with advanced non-small cell lung cancer (NSCLC). The fast time to market of anlotinib hydrochloride was made possible by the Chinese government's support for accelerated evaluation and approval of innovative drugs.

According to CRI's market research, as of September 2021, anlotinib has been approved in China for four indications: (1) advanced NSCLC (2) soft tissue sarcomas (3) small cell lung cancer (4) advanced or metastatic medullary thyroid cancer.

In 2020, there were 4.57 million new cancer cases in China, 820,000 of which were lung cancer cases. Lung cancer is mainly divided into small cell lung cancer and non-small cell lung cancer (NSCLC), and the latter accounts for about 80-85% among all patients with lung cancer, most of which are diagnosed as locally advanced or metastatic disease. Soft tissue sarcomas are a group of rare cancers with low incidence that account for only 1% of all malignancies. But it is characterized by high evolution possibility, poor prognosis, high insidiousness, and inconspicuous early symptoms, making it extremely difficult to treat clinically. According to CRI's estimation, there were about 220,000 new cases of thyroid cancer in China in 2020, among which medullary thyroid carcinoma (MTC) accounts for about 2%-4%. MTC is more likely to have malignant evolution and distant metastasis, and the treatment may not impose good effects for patients with advanced stage.

According to CRI's market research, the sales value of anlotinib in the Chinese market was approximately CNY922 million (USD142 million) in 2020, with a CAGR of 444% from 2018 to 2020. Generic drugs of anlotinib from other Chinese pharmaceutical companies are expected to be on the market around 2024, so China's anlotinib market will remain fully occupied by Chia Tai Tianqing Pharmaceutical's product till 2025.

CRI expects that China's anlotinib market will continue to grow from 2021 to 2025 as new cancer cases are expected to increase in China due to environmental pollution and lifestyle changes.

Topics Covered:

Impact of COVID-19 on China's Anlotinib Hydrochloride Market?

The Incidence of Cancers in China?

Development Environment of Anlotinib Hydrochloride in China?

Sales Volume of Anlotinib Hydrochloride in China?

Sales Volume and Value of Anlotinib Hydrochloride in China by Region?

Major Anlotinib Hydrochloride Manufacturers in China and Their Market Shares?

Sales Price of Anlotinib Hydrochloride in China?

Major Anlotinib Hydrochloride Producers in China?

Prospects of China's Anlotinib Hydrochloride Market, 2021-2025?

Research Report on China's Anlotinib Hydrochloride Market, 2021-2025

Table of Contents

1 Relevant Concepts of Anlotinib Hydrochloride
1.1 Indications of Anlotinib Hydrochloride
1.2 Development of China's Anlotinib Hydrochloride Market
1.3 Governmental Approval of Anlotinib Hydrochloride in China
1.4 The Impact of COVID-19 on China's Anlotinib Hydrochloride Market

2 Sales of Anlotinib Hydrochloride in China, 2016-2020
2.1 Sales Value
2.1.1 Sales Value in China
2.1.2 Sales Value in China by Region
2.2 Sales Volume
2.2.1 Sales Volume in China
2.2.2 Sales Volume in China by Region
2.3 Sales of Anlotinib Hydrochloride in China by Dosage Form, 2016-2020
2.3.1 Capsules
2.3.2 Other Dosage Forms

3 Analysis of Major Anlotinib Hydrochloride Manufacturers in China, 2020
3.1 Analysis of Market Share
3.1.1 Market Share of Manufacturers by Sales Value
3.1.2 Market Share of Manufacturers by Sales Volume
3.2 Nanjing Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
3.2.1 Company Profile
3.2.2 Sales of Anlotinib Hydrochloride in China

4 Sales Price of Anlotinib Hydrochloride of Different Companies in China, 2020-2021
4.1 Nanjing Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (FuKeWei®)
4.2 Other Key Players

5 Prospects of China's Anlotinib Hydrochloride Market, 2021-2025
5.1 Influencing Factors for the Market Development
5.1.1 The Impact of COVID-19 on the Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend

List of Charts
Chart Patent Information of Anlotinib Hydrochloride in China
Chart Sales Value of Anlotinib Hydrochloride in China, 2016-2020
Chart Sales Volume of Anlotinib Hydrochloride in China, 2016-2020
Chart Sales Value of Anlotinib Hydrochloride Capsules in China, 2016-2020
Chart Sales Value and Volume of Anlotinib Hydrochloride (of Nanjing Chia Tai Tianqing Pharmaceutical Group Co., Ltd.) in China, 2016-2020
Chart Sales Price of FuKeWei (Anlotinib Hydrochloride of Nanjing Chia Tai Tianqing Pharmaceutical Group Co., Ltd.) in China, 2020
Chart Forecast on Sales Value of Anlotinib Hydrochloride in China, 2021-2025
Chart Forecast on Sales Volume of Anlotinib Hydrochloride in China, 2021-2025
  • Global Oral Hypoglycemic Agents (OHAs) Market Insights and Forecast to 2028
    Published: 27-Jan-2022        Price: US 4900 Onwards        Pages: 107
    Oral Hypoglycemic Agents (OHAs) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Oral Hypoglycemic Agents (OHAs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Sulfonylureas - Metformin - Thiazolidinediones - Alpha-Glucosi......
  • Global Antibiotics Drugs Market Insights and Forecast to 2028
    Published: 27-Jan-2022        Price: US 4900 Onwards        Pages: 111
    Antibiotics Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Antibiotics Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Phenicols - Quinolones - Macrolides - Sulfonamides - Aminoglycosides - Tetra......
  • Global Acetohydroxamic Acid Market Insights and Forecast to 2028
    Published: 27-Jan-2022        Price: US 4900 Onwards        Pages: 95
    Acetohydroxamic Acid market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Acetohydroxamic Acid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - 99% Segment by Application - Capsule - Other......
  • Global Veterinary/Animal Vaccines Market Insights and Forecast to 2028
    Published: 27-Jan-2022        Price: US 4900 Onwards        Pages: 110
    Veterinary/Animal Vaccines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Veterinary/Animal Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Live Attenuated Vaccines - Inactivated Vaccines - Toxoid Vaccines - Reco......
  • Global Podiatric Products Market Insights and Forecast to 2028
    Published: 27-Jan-2022        Price: US 4900 Onwards        Pages: 90
    Podiatric Products market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Podiatric Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Alignate Dressing - Hydrogel Dressing - Collagen Dressing Segment by Application......
  • Global Type 1 Diabetes Drugs Market Insights and Forecast to 2028
    Published: 27-Jan-2022        Price: US 4900 Onwards        Pages: 112
    Type 1 Diabetes Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Type 1 Diabetes Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Insulins - Others Segment by Application - Drugstore - Hospital......
  • Global Liver Cirrhosis Therapeutics Market Insights and Forecast to 2028
    Published: 27-Jan-2022        Price: US 4900 Onwards        Pages: 114
    Liver Cirrhosis Therapeutics market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Liver Cirrhosis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Oral - Injection Segment by Application - Hospital - ......
  • Global B4GN4 Antibody Market Insights and Forecast to 2028
    Published: 27-Jan-2022        Price: US 4900 Onwards        Pages: 93
    B4GN4 Antibody market is segmented by Type and by Application. Players, stakeholders, and other participants in the global B4GN4 Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - pAbs - mAb Segment by Application - BioScience Companies - Hospitals and Clinics......
  • Global B3GL2 Antibody Market Insights and Forecast to 2028
    Published: 27-Jan-2022        Price: US 4900 Onwards        Pages: 73
    B3GL2 Antibody market is segmented by Type and by Application. Players, stakeholders, and other participants in the global B3GL2 Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - pAbs - mAb Segment by Application - BioScience Companies - Hospitals and Clinics......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs